Stock listing
NASDAQ:PMVP PMV Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of PMV Pharmaceuticals, Inc.
Follow PMV Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:PMVP
$0.876 USD -0.434 (-33.1%)
Close on Nov 20, 2026
- Day range
- $0.660 – $1.340 USDNov 20, 2026
- Volume
- 4.81M sharesNov 20, 2026
- Market cap
- $66.17M USDAt the close on Nov 20, 2026 · price × 75.53M shares outstanding
- 52-week range
- $0.660 – $1.910 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1.06M USDMedian day 468,500 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PMVP · Home | $0.876 USD | -0.434 (-33.1%) | 4,810,663 | $1.340 | $1.340 | $0.660 | $1.310 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PMVP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.876 | -0.434 | -33.1% | $1.340 | $1.340 | $0.660 | 4,810,663 | |
| $1.310 | +0.090 | +7.4% | $1.240 | $1.330 | $1.230 | 1,196,295 | |
| $1.220 | 0.000 | 0.0% | $1.210 | $1.280 | $1.190 | 430,866 | |
| $1.220 | +0.030 | +2.5% | $1.220 | $1.230 | $1.070 | 720,343 | |
| $1.190 | -0.080 | -6.3% | $1.270 | $1.300 | $1.180 | 585,651 | |
| $1.270 | +0.060 | +5.0% | $1.220 | $1.270 | $1.190 | 290,800 | |
| $1.210 | -0.050 | -4.0% | $1.250 | $1.269 | $1.180 | 353,400 | |
| $1.260 | +0.040 | +3.3% | $1.230 | $1.270 | $1.230 | 154,100 | |
| $1.220 | -0.030 | -2.4% | $1.230 | $1.260 | $1.175 | 584,800 | |
| $1.250 | -0.010 | -0.8% | $1.270 | $1.310 | $1.240 | 189,400 | |
| $1.260 | -0.015 | -1.2% | $1.280 | $1.290 | $1.240 | 194,300 | |
| $1.275 | -0.050 | -3.8% | $1.300 | $1.300 | $1.200 | 475,600 | |
| $1.325 | -0.055 | -4.0% | $1.400 | $1.440 | $1.305 | 529,800 | |
| $1.380 | +0.010 | +0.7% | $1.370 | $1.420 | $1.330 | 458,200 | |
| $1.370 | +0.060 | +4.6% | $1.310 | $1.400 | $1.310 | 440,400 | |
| $1.310 | -0.040 | -3.0% | $1.330 | $1.331 | $1.210 | 1,212,800 | |
| $1.350 | -0.030 | -2.2% | $1.390 | $1.390 | $1.330 | 238,100 | |
| $1.380 | +0.130 | +10.4% | $1.250 | $1.390 | $1.220 | 348,900 | |
| $1.250 | +0.120 | +10.6% | $1.170 | $1.280 | $1.155 | 375,169 | |
| $1.130 | -0.140 | -11.0% | $1.260 | $1.285 | $1.100 | 648,579 | |
| $1.270 | -0.035 | -2.7% | $1.300 | $1.330 | $1.255 | 171,000 | |
| $1.305 | -0.055 | -4.0% | $1.360 | $1.370 | $1.300 | 128,600 | |
| $1.360 | -0.030 | -2.2% | $1.370 | $1.410 | $1.350 | 236,600 | |
| $1.390 | +0.135 | +10.8% | $1.260 | $1.410 | $1.260 | 347,600 | |
| $1.255 | +0.045 | +3.7% | $1.210 | $1.290 | $1.210 | 196,000 | |
| $1.210 | -0.080 | -6.2% | $1.280 | $1.300 | $1.200 | 357,600 | |
| $1.290 | +0.050 | +4.0% | $1.260 | $1.330 | $1.240 | 376,600 | |
| $1.240 | -0.110 | -8.1% | $1.330 | $1.370 | $1.230 | 525,800 | |
| $1.350 | -0.060 | -4.3% | $1.400 | $1.466 | $1.315 | 541,300 | |
| $1.410 | -0.110 | -7.2% | $1.550 | $1.550 | $1.400 | 398,600 | |
| $1.520 | +0.030 | +2.0% | $1.490 | $1.610 | $1.480 | 891,700 | |
| $1.490 | -0.010 | -0.7% | $1.510 | $1.540 | $1.460 | 461,400 | |
| $1.500 | -0.110 | -6.8% | $1.590 | $1.600 | $1.480 | 607,400 | |
| $1.610 | -0.170 | -9.6% | $1.780 | $1.810 | $1.591 | 616,100 | |
| $1.780 | -0.010 | -0.6% | $1.800 | $1.840 | $1.700 | 1,185,500 | |
| $1.790 | +0.040 | +2.3% | $1.750 | $1.870 | $1.680 | 3,735,800 | |
| $1.750 | +0.080 | +4.8% | $1.680 | $1.910 | $1.630 | 1,647,200 | |
| $1.670 | +0.240 | +16.8% | $1.440 | $1.725 | $1.440 | 3,124,700 | |
| $1.430 | +0.070 | +5.1% | $1.370 | $1.450 | $1.360 | 550,900 | |
| $1.360 | +0.030 | +2.3% | $1.340 | $1.390 | $1.300 | 336,100 | |
| $1.330 | -0.005 | -0.4% | $1.320 | $1.380 | $1.290 | 271,200 | |
| $1.335 | -0.035 | -2.6% | $1.360 | $1.400 | $1.280 | 486,300 | |
| $1.370 | -0.140 | -9.3% | $1.510 | $1.520 | $1.365 | 570,700 | |
| $1.510 | +0.035 | +2.4% | $1.470 | $1.525 | $1.460 | 316,900 | |
| $1.475 | -0.025 | -1.7% | $1.500 | $1.510 | $1.445 | 330,000 | |
| $1.500 | +0.040 | +2.7% | $1.460 | $1.520 | $1.430 | 1,184,900 | |
| $1.460 | +0.030 | +2.1% | $1.430 | $1.500 | $1.420 | 430,800 | |
| $1.430 | +0.070 | +5.1% | $1.370 | $1.510 | $1.370 | 1,021,700 | |
| $1.360 | -0.100 | -6.8% | $1.450 | $1.450 | $1.350 | 705,400 | |
| $1.460 | +0.060 | +4.3% | $1.420 | $1.495 | $1.380 | 1,109,800 | |
| $1.400 | -0.040 | -2.8% | $1.450 | $1.505 | $1.400 | 538,600 | |
| $1.440 | +0.065 | +4.7% | $1.340 | $1.450 | $1.340 | 673,600 | |
| $1.375 | +0.035 | +2.6% | $1.340 | $1.390 | $1.340 | 419,100 | |
| $1.340 | +0.050 | +3.9% | $1.310 | $1.375 | $1.290 | 1,163,500 | |
| $1.290 | +0.050 | +4.0% | $1.240 | $1.350 | $1.240 | 530,000 | |
| $1.240 | -0.020 | -1.6% | $1.260 | $1.289 | $1.199 | 576,300 | |
| $1.260 | -0.030 | -2.3% | $1.260 | $1.290 | $1.242 | 704,300 | |
| $1.290 | +0.080 | +6.6% | $1.150 | $1.310 | $1.115 | 6,823,800 | |
| $1.210 | -0.010 | -0.8% | $1.240 | $1.240 | $1.210 | 1,115,500 | |
| $1.220 | -0.020 | -1.6% | $1.250 | $1.250 | $1.215 | 90,900 | |
| $1.240 | -0.070 | -5.3% | $1.300 | $1.310 | $1.220 | 197,500 | |
| $1.310 | +0.005 | +0.4% | $1.300 | $1.320 | $1.295 | 94,500 | |
| $1.305 | 0.000 | 0.0% | $1.310 | $1.320 | $1.290 | 211,700 | |
| $1.305 | -0.025 | -1.9% | $1.340 | $1.360 | $1.300 | 168,300 | |
| $1.330 | +0.030 | +2.3% | $1.320 | $1.340 | $1.300 | 131,300 | |
| $1.300 | +0.020 | +1.6% | $1.290 | $1.350 | $1.270 | 458,100 |
- Ticker
- NASDAQ:PMVP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 20, 2026
PMV Pharmaceuticals Announces Promising Updated Data From the PYNNACLE Phase 2 Pivotal Trial of Rezatapopt Monotherapy in Patients With TP53 Y220C-Mutated Advanced Solid Tumors
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 27 slides
Latest news
PMV Pharmaceuticals Announces Promising Updated Data From the PYNNACLE Phase 2 Pivotal Trial of Rezatapopt Monotherapy in Patients With TP53 Y220C-Mutated Advanced Solid Tumors
Nov 20, 2026
Closed $0.876 (-33.1%) on Nov 20, 2026
PMV Pharmaceuticals Reports Third Quarter 2026 Financial Results and Corporate Highlights
Nov 10, 2026
Closed $1.22 (-2.4%) on Nov 10, 2026
Pivotal Phase 2 Rezatapopt PYNNACLE Data to Be Featured in Late-Breaking Oral Presentation at ENA 2026
Nov 4, 2026
Closed $1.33 (-4.0%) on Nov 4, 2026
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors
Oct 5, 2026
Closed $1.78 (-0.6%) on Oct 5, 2026
PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer
Sep 8, 2026
Closed $1.34 (+3.9%) on Sep 8, 2026
PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities
Aug 31, 2026
Closed $1.29 (+6.6%) on Sep 1, 2026
PMV Pharma Announces Proposed Public Offering of Securities
Aug 31, 2026
Closed $1.29 (+6.6%) on Sep 1, 2026
PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial
Aug 31, 2026
Closed $1.29 (+6.6%) on Sep 1, 2026
PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights
Aug 14, 2026
Closed $1.26 (+3.7%) on Aug 14, 2026
PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights
May 12, 2026
Closed $1.42 (+2.2%) on May 12, 2026
Financings
Public offering of common stock and accompanying warrants, or pre-funded warrants and accompanying warrants
Sep 1, 2026
Announced: about US$50.8M · US$1.21 a share · 1 warrant at US$1.21 for 60 months · TD Cowen
Dealers: TD Cowen (lead)
Decks
Investor Presentation (September 2026)
Investor deck · 27 slides · September 2026
Investor Presentation (September 2025)
Investor deck · 43 slides · Sep 10, 2025
Technical Presentation (October 2023)
Technical · 25 slides · Oct 12, 2023
ASCO 2022 PC14586 Investor Event
Conference · 32 slides · Jun 8, 2022
PMV Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 57 in all · newest Nov 20, 2026 · oldest 2020
- Decks
- 5 decks · latest September 2026
Where PMV Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PMVP · Home listing · This page | NASDAQ | United States | USD |
| BOATS:PMVP | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about PMV Pharmaceuticals, Inc.